116 related articles for article (PubMed ID: 3019948)
1. The effect of DMSO treatment on the composition of 99mTc(Sn)EHDP.
de Groot GJ; Das HA; de Ligny CL
Int J Rad Appl Instrum A; 1986; 37(6):487-90. PubMed ID: 3019948
[TBL] [Abstract][Full Text] [Related]
2. The separation of 99mTc(Sn)EHDP complexes by HPLC and GPC.
de Groot GJ; Das HA; de Ligny CL
Int J Rad Appl Instrum A; 1986; 37(1):23-7. PubMed ID: 3019923
[TBL] [Abstract][Full Text] [Related]
3. The influence of the method of preparation of the bone scanning agent 99mTc(Sn)EHDP on its tissue distribution in the rat.
Van den Brand JA; Das HA; Dekker BG; de Ligny CL; Van den Hamer CJ
Int J Appl Radiat Isot; 1982 Oct; 33(10):917-28. PubMed ID: 6818161
[TBL] [Abstract][Full Text] [Related]
4. Gel chromatographic analysis of the bone seeking radiopharmaceutical 99mTc(Sn)-EHDP: the influence of pH and EHDP-concentration on the size of its constituents.
Huigen YM; Gelsema WJ; de Ligny CL
Int J Rad Appl Instrum A; 1987; 38(8):615-8. PubMed ID: 2822619
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-labelled Cu(I)-EHDP, a potential skeletal imaging agent.
Agha NH; Al-Hilli AM; Hassen HA
Nuklearmedizin; 1981 Dec; 20(6):299-304. PubMed ID: 6799937
[TBL] [Abstract][Full Text] [Related]
6. Improvement of the reproducibility of ion-pair HPLC of 99mTc(Sn)EHDP complexes and the influence of the Sn(II) concentration on the composition of the reaction mixture.
Nieuwland RJ; Das HA; de Ligny CL
Int J Rad Appl Instrum A; 1989; 40(2):153-7. PubMed ID: 2541105
[TBL] [Abstract][Full Text] [Related]
7. The effect of DMSO treatment on the performance of [99mTc]HEDP.
Bugaj JE; Esser PD; Tofe AJ; Borgia AT; Fawwaz RA
Int J Nucl Med Biol; 1984; 11(2):109-11. PubMed ID: 6434460
[TBL] [Abstract][Full Text] [Related]
8. The effect of the reduction method on the composition of 99mTc-EHDP complexes.
de Groot GJ; Das HA; de Ligny CL
Int J Rad Appl Instrum A; 1987; 38(8):611-4. PubMed ID: 2822618
[TBL] [Abstract][Full Text] [Related]
9. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
[TBL] [Abstract][Full Text] [Related]
11. Visualization of the liver with 99mTc-EHDP in thalassemia major.
Valdez VA; Jacobstein JG
Gastrointest Radiol; 1981; 6(2):175-6. PubMed ID: 6788639
[TBL] [Abstract][Full Text] [Related]
12. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
Schümichen C; Hohloch M; Hoffmann G
Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatography of tin-reduced technetium hydroxyethylidene diphosphonate complexes for on-line spectral characterization and double isotope labeling.
Mikelsons MV; Pinkerton TC
Anal Chem; 1986 May; 58(6):1007-13. PubMed ID: 3087235
[No Abstract] [Full Text] [Related]
14. The influence of experimental conditions on the formation of various 99mTc(Sn)EHDP complexes.
van den Brand JA; Das HA; Dekker BG; de Ligny L
Int J Appl Radiat Isot; 1982 Jan; 33(1):39-45. PubMed ID: 6800964
[No Abstract] [Full Text] [Related]
15. [Thyroid cancer with a ring-shaped accumulation of 99mTc-EHDP: a case report (author's transl)].
Kumano M
Kaku Igaku; 1980 Jul; 17(5):589-92. PubMed ID: 6775117
[No Abstract] [Full Text] [Related]
16. Investigation of two new [99mTc]Tc-HEDP preparations that can be expected to give a better lesion-to-normal-bone uptake ratio when used as bone scanning agents.
de Ligny CL; Gelsema WJ; Hoevelaken TP; Schuring J
Nucl Med Biol; 1993 Jan; 20(1):23-9. PubMed ID: 8461877
[TBL] [Abstract][Full Text] [Related]
17. 99mTc bone scanning agents--III. Preparation and gel chromatography of 99mTc(Sn)MDP complexes.
Kroesbergen J; Gelsema WJ; de Ligny CL
Int J Nucl Med Biol; 1986; 12(6):419-24. PubMed ID: 3710704
[TBL] [Abstract][Full Text] [Related]
18. Bone extraction and blood clearance of diphosphonate in the dog.
Hughes SP; Davies DR; Bassingthwaighte JB; Knox FG; Kelly PJ
Am J Physiol; 1977 Mar; 232(3):H341-7. PubMed ID: 402827
[TBL] [Abstract][Full Text] [Related]
19. A radiopharmaceutical and clinical comparison of 99mTc-Sn-hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate.
Silberstein EB
Radiology; 1980 Sep; 136(3):747-51. PubMed ID: 6773104
[TBL] [Abstract][Full Text] [Related]
20. [Study on tumor affinity of technetium-99m-labeled radiopharmaceuticals. (2) 99mTc-Sn-diphosphonate (99mTc-EHDP), 99mTc-Sn-dimercaptosuccinic acid (99mTc-DMSA), and 99mTc-Sn-diethyl stilbestrol diphosphate (99mTc-DSDP)].
Ito K; Kobayashi S; Hisada K; Tonami N; Ando A
Radioisotopes; 1976 Oct; 25(10):622-9. PubMed ID: 1037404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
